1 October 2025 – On 1 October 2025, the updated guidance document Meetings for applicants for authorization procedures entered into force. Within the framework of this document, the Preliminary Decision Clarification Meeting for human medicinal products is introduced. This meeting provides applicants with an additional opportunity to engage in dialogue with Swissmedic and clarify any questions regarding the issues communicated in the preliminary decision.

For more information, see here.